akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 126 blog entries.

MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited)

MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) Drug alert number: EL(26)A/42 Date issued: 12 October 2026 Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations. DMRC reference number: DMRC-41054154 Company name: [...]

The post MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) appeared first on Community Pharmacy England.

By |October 13th, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited)

Medicine Supply Notification: Lacidipine 2mg and 4mg tablets

The Department of Health and Social Care (DHSC) has issued a medicine supply notification (MSN) for: Lacidipine 2mg and 4mg tablets. MSN/2026/046 Tier 2 – medium impact Date of issue: 6 October 2026 Lacidipine 2mg and 4mg tablets are out of stock until early November 2026 Lercanidipine 10mg and 20mg tablets remain available and can [...]

The post Medicine Supply Notification: Lacidipine 2mg and 4mg tablets appeared first on Community Pharmacy England.

By |October 6th, 2026|Lexpos News|Comments Off on Medicine Supply Notification: Lacidipine 2mg and 4mg tablets

MHRA Class 3 Medicines Recall: MOVICOL Plain 13.7g powder for oral solution (Norgine Limited)

MHRA Class 3 Medicines Recall: MOVICOL Plain 13.7g powder for oral solution (Norgine Limited) Drug Alert Number: EL(26)A/41 Date issued: 5 October 2026 Norgine Limited is recalling specific batches of product as a precautionary measure due to some units containing the incorrect amounts of active ingredients. DMRC reference number:DMRC-40129134 Marketing Authorisation Holder: Norgine Limited Medicine Details [...]

The post MHRA Class 3 Medicines Recall: MOVICOL Plain 13.7g powder for oral solution (Norgine Limited) appeared first on Community Pharmacy England.

By |October 5th, 2026|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: MOVICOL Plain 13.7g powder for oral solution (Norgine Limited)

National Patient Safety Alert: Levemir® (insulin detemir) FlexPen® and Levemir® (insulin detemir) Penfill®

National Patient Safety Alert: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml prefilled pens and; Levemir® (insulin detemir) Penfill® 100units/ml solution for injection 3ml cartridges National Patient Safety Alert Reference Number: NatPSA/2026/006/DHSC Date issued: 1 October 2026 Explanation of identified safety issue This alert is to supplement previous communications issued: Medicine Supply Notification (MSN/2025/036) [...]

The post National Patient Safety Alert: Levemir® (insulin detemir) FlexPen® and Levemir® (insulin detemir) Penfill® appeared first on Community Pharmacy England.

By |October 1st, 2026|Lexpos News|Comments Off on National Patient Safety Alert: Levemir® (insulin detemir) FlexPen® and Levemir® (insulin detemir) Penfill®

Upcoming changes to Part IX of the Drug Tariff on-demand webinar

Community Pharmacy England and the Department of Health and Social Care (DHSC) held a joint webinar on Tuesday 22nd September 2026 to explain the upcoming changes to Part IX of the Drug Tariff. Part IX of the Drug Tariff lists all the medical devices (appliances) allowed to be prescribed on NHS prescriptions in England.  Following [...]

The post Upcoming changes to Part IX of the Drug Tariff on-demand webinar appeared first on Community Pharmacy England.

By |September 25th, 2026|Lexpos News|Comments Off on Upcoming changes to Part IX of the Drug Tariff on-demand webinar